Hikma's generic Vascepa provides a treatment to be used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia.
Former Bristol Myers Squibb executive Bill Szablewski will serve as head of capital markets for Viatris, the company being created by the merger of Mylan and Pfizer's Upjohn.